Interpretation of genotype and pharmacokinetics for resistance to fosamprenavir-ritonavir-based regimens in antiretroviral-experienced patients.
Pellegrin I, Breilh D, Coureau G, Boucher S, Neau D, Merel P, Lacoste D, Fleury H, Saux MC, Pellegrin JL, Lazaro E, Dabis F, Thiébaut R; ANRS Co3 Aquitaine Cohort.
Pellegrin I, et al. Among authors: saux mc.
Antimicrob Agents Chemother. 2007 Apr;51(4):1473-80. doi: 10.1128/AAC.00481-06. Epub 2007 Feb 12.
Antimicrob Agents Chemother. 2007.
PMID: 17296739
Free PMC article.